(Q49899018)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Yuri Lebedev

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Anastasiia L Sycheva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ekaterina A Komech

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Anastasia A Minervina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ivan V Zvyagin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Dmitriy B Staroverov

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Dmitriy M Chudakov

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ilgar Z Mamedov

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

15 February 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

1599-1605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines

17 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Efficacy and effectiveness of live attenuated influenza vaccine in school-age children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

US authorities discourage use of nasal influenza vaccine, citing ineffectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Universal influenza virus vaccines and therapeutic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Correlates of protection against influenza infection in humans--on the path to a universal vaccine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Correlates of protection to influenza virus, where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Novel universal influenza virus vaccine approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Cytotoxic T-cell immunity to influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Cellular immune correlates of protection against symptomatic pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Advances in the development of influenza virus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Phenotypic Changes in Influenza‐Specific CD8+T Cells after Immunization of Children and Adults with Influenza Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Persisting fetal clonotypes influence the structure and overlap of adult human T cell receptor repertoires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Towards error-free profiling of immune repertoires.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

MiXCR: software for comprehensive adaptive immunity profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Counting absolute numbers of molecules using unique molecular identifiers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Dynamics of Individual T Cell Repertoires: From Cord Blood to Centenarians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

Human CD4+ T-cell recognition of influenza A virus hemagglutinin after subunit vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.02.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2018.02.027

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29454515%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference